---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-140017"
form_type: "8-K"
ticker: "ADPT"
cik: "0001478320"
company_name: "Adaptive Biotechnologies Corp"
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:32:48.237393+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Adaptive Biotechnologies shareholders elect Chad Robins and approve say-on-pay, auditor

## Summary
- Chad Robins elected Class III director with 80.95% of votes cast; 12.8M broker non-votes.
- Say-on-pay advisory proposal passed with 98.46% support; 1.23% against.
- Ratification of Ernst & Young as 2025 auditor approved with 99.91% of votes.

## SEC filing metadata
- accession: 0001193125-25-140017
- form_type: 8-K
- ticker: ADPT
- cik: 0001478320
- company_name: Adaptive Biotechnologies Corp
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1478320/000119312525140017/0001193125-25-140017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1478320/000119312525140017/d98087d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-140017
- JSON: https://secwatch.observer/filing/0001193125-25-140017.json
- Plain text: https://secwatch.observer/filing/0001193125-25-140017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.